CD4 and pancreatic adenocarcinoma: We demonstrated that EGCG down-regulated IL-1R expression in CD4+ T cells, which was consistent with previous reports that EGCG reduced IL-1R expression in the pancreatic adenocarcinoma cells [10], although a different cell type.